血浆置换用于需心室辅助装置的血栓性血小板减少症患者
Plasmapheresis in Patients With Heparin-induced Thrombocytopenia Requiring Ventricular Assist Device.
PubMed 文献 · Ann Thorac Surg · 2019-11-09
本文报告2例经5-羟色胺释放试验确诊肝素诱导的血小板减少症(HIT)患者,在置入左心室辅助装置(LVAD)前接受血浆置换治疗并获成功。提示血浆置换或可为需LVAD的HIT患者提供术前抗凝替代策略。
要点
- HIT患者行LVAD置入存在免疫介导血栓事件风险
- 血浆置换可在LVAD置入前用于HIT患者
- 两例均经5-羟色胺释放试验确诊HIT
核心结论
- 经5-羟色胺释放试验确诊的HIT患者,在LVAD置入前接受血浆置换治疗可获成功。
研究设计与样本
- 病例报告,共2例经5-羟色胺释放试验确诊HIT并需置入LVAD的患者。
主要发现
- 2例HIT患者在LVAD置入前接受血浆置换治疗,治疗均获成功。
临床怎么用
- 对需LVAD置入的HIT患者,可考虑在术前采用血浆置换以降低免疫介导血栓风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Anticoagulation with unfractionated heparin is vital to reduce the risk of thromboembolic events during cardiopulmonary bypass and left ventricular assist device placement. However patients with heparin-induced thrombocytopenia are at risk of developing immune-mediated thrombotic events. We describe 2 patients with heparin-induced thrombocytopenia confirmed via serotonin release assay who were successfully treated with plasmapheresis exchange before left ventricular assist device placement.
来源:Ann Thorac Surg,查看原文。版权归原作者所有。
引用
- Maffei SR, Lamba HK, Mensah CK, et al. Plasmapheresis in Patients With Heparin-induced Thrombocytopenia Requiring Ventricular Assist Device. Ann Thorac Surg. 2019. PMID: 31715152. doi:10.1016/j.athoracsur.2019.09.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。